Speaker: Stefania Manetti, PhD candidate in Healthcare Innovation Management at Sant’Anna School of Advanced Studies in Pisa (Italy), where she graduated with honors in Biomedical Engineering in 2014. In 2016, she visited the Public Health Sciences Department of Karolinska Institutet (Stockholm, Sweden) to work on parametric survival models and their application in decision models. She is currently a visiting scholar at the Health Economics Research Center (HERC), University of Oxford, to investigate the impact of hospital costing methods on cost-effectiveness analysis. Her research interests include Health Technology Assessment (HTA) and early HTA for innovative medical devices, cost-effectiveness analysis and decision models. Stefania is also the President of the International Society of Pharmacoeconomics and Outcome Research (ISPOR) Student chapter at Sant’Anna School of Advanced Studies.

Aim: After introducing the main principles of the cost-effectiveness approach consistent with the mainstream Health Technology Assessment (HTA) framework, this talk will explore the early HTA state of art and whether it could support the development process and provide a more solid foundation for the next phase of the reimbursement strategy.

Room/time: room D202, School of Engineering, University of Warwick, 14:00.